Health
Explainer
Landmark Global Consensus Redefines Heart Failure, Updating Diagnosis and Treatment for 64 Million People
5 sources · 70d ago
Genomic Testing
Landmark Phase 3 Trial Shows Genomic Test Safely Spares Two-Thirds of High-Risk Breast Cancer Patients from Chemotherapy
4 sources · 64d ago
Deep Dive
Landmark Trials Test Existing Drugs to Treat Long COVID by Targeting Inflammation and Blood Flow
5 sources · 70d ago
More in Health
Contraceptive TechRegulatory Approval
FDA Approves Nexplanon for Five Years of Contraception, Up From Three
Reproductive Health Clinicians 41%Patient Advocates 35%Regulatory Authorities 24%
5 sources · 70d ago
ExplainerDermatology Breakthrough
Phase 3 Trial Shows Sonelokimab Achieves Durable, Near-Complete Clearance in One-Third of Hidradenitis Suppurativa Patients
Dermatologists & Clinicians 40%Patient Advocacy Groups 35%Biotech Analysts 25%
2 sources · 70d ago
ExplainerMetabolic Health
FDA Grants Tentative Approval to First Generic Injectable Semaglutide, Signaling Future Price Competition
Generic Manufacturers 38%Originator Companies 38%Regulatory Bodies 25%
4 sources · 70d ago
ExplainerVaccine Tech
FDA Committee Unanimously Backs Moderna's mRNA Flu Shot for Older Adults
Public Health Consensus 45%Regulatory Oversight 30%Biotech Innovators 25%
3 sources · 70d ago
ExplainerInfant Development
Landmark Study Links Screen Time in Under-Twos to Long-Term Developmental and Health Risks
Early Childhood Researchers 40%Parental Support Advocates 30%Public Health Officials 30%
4 sources · 70d ago
Research BriefHepatitis B Cure
The Evidence Pack: How a Novel Antisense Oligonucleotide Achieves a Functional Cure in Chronic Hepatitis B
Clinical Hepatologists 40%Virology & Mechanism Researchers 30%Industry & Public Health Analysts 30%
5 sources · 71d ago
Research BriefMetabolic Health
The Evidence Pack: How the First Once-Weekly Insulin is Rewriting Type 2 Diabetes Management
Endocrinologists & Clinicians 40%Drug Safety Regulators 35%Pharmaceutical Developers 25%
3 sources · 71d ago
ExplainerNeuromodulation
The Evidence Pack: How At-Home Brain Stimulation is Rewiring the Treatment of Depression
Clinical Researchers 39%Psychiatric Practitioners 39%Device Manufacturers 22%
6 sources · 71d ago
Eczema TreatmentExplainer
FDA Approves Ebglyss for Atopic Dermatitis With Six-Injections-Per-Year Maintenance Dosing
Clinical Dermatologists 40%Patient Advocates 35%Market Analysts 25%
4 sources · 71d ago
ExplainerGlioblastoma Research
Novel Vitamin B12 Compound Crosses Blood-Brain Barrier to Target Glioblastoma Tumors
Oncology Researchers 47%Clinical Skeptics 35%Patient Advocates 18%
2 sources · 71d ago
ExplainerCellular Aging
Scientists Identify New Stem Cell Type as Key Biological Driver of Age-Related Belly Fat
Metabolic Researchers 40%Longevity Scientists 30%Public Health Advocates 30%
3 sources · 71d ago
ExplainerAllergy Care
First-Ever Oral Epinephrine Tablet Approved for Emergency Treatment of Severe Allergic Reactions
Allergy Patients & Caregivers 35%Clinical Allergists 35%Pharmaceutical Developers 30%
2 sources · 71d ago
ExplainerAlzheimer's Biomarkers
Landmark Study Finds Blood Test Can Predict Alzheimer's Risk Up to 25 Years Before Symptoms
Clinical Researchers 40%Patient Advocacy Groups 30%Diagnostic Ethicists 30%
3 sources · 71d ago
Blindspot
Important stories the mainstream barely covered
High-impact news with only 1–3 outlets covering it. These stories matter — they just didn't make the radar.